Gene expression analysis for EPHA2 (EPH receptor A2), EPHB2 (EPH receptor B2), S100A9 (S100 calcium binding protein A9), PBEF (S100 calcium binding protein A8), LILRB2 (nicotinamide phosphoribosyltransferase), PLAUR (leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2), LTB (plasminogen activator, urokinase receptor), WNT5A (lymphotoxin beta (TNF superfamily, member 3)), WNT5A (wingless-type MMTV integration site family, member 5A) has been performed using real-time polymerase chain reaction in affected skin biopsies from patients with psoriasis versus visually unaffected skin of the same 18 patients. It was revealed that the expression of the nine examined genes was upregulated in the affected by psoriasis compared to visually unaffected skin samples. The highest expression was observed for S100A9, S100A8, PBEF, WNT5A2, and EPHB2 genes. S100A9 and S100A8 gene expression in the affected skin samples was 100-fold higher than in visually intact skin while PBEF, WNT5A, and EPHB2 gene expression was upregulated more than fivefold. We suppose that the high expression of these genes might be associated with the severity of the disease. Moreover, the transcriptional activity of these genes might serve a molecular indicator of the efficacy of treatment of psoriasis.
Russian Journal of Genetics – Springer Journals
Published: Oct 10, 2013
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera